Find Eribulin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Halaven, Eribulin mesilate, 441045-17-6, Eribulin (mesylate), Eribulin mesylate [usan], Eribulin (as mesylate)
Molecular Formula
C41H63NO14S
Molecular Weight
826.0  g/mol
InChI Key
QAMYWGZHLCQOOJ-WRNBYXCMSA-N
FDA UNII
AV9U0660CW

Eribulin
Eribulin Mesylate is the mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression.
1 2D Structure

Eribulin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic acid
2.1.2 InChI
InChI=1S/C40H59NO11.CH4O3S/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41;1-5(2,3)4/h19,23-39,43H,2-3,5-18,41H2,1,4H3;1H3,(H,2,3,4)/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+;/m1./s1
2.1.3 InChI Key
QAMYWGZHLCQOOJ-WRNBYXCMSA-N
2.1.4 Canonical SMILES
CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O.CS(=O)(=O)O
2.1.5 Isomeric SMILES
C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O.CS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
AV9U0660CW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. B 1793

2. B 1939

3. B-1793

4. B-1939

5. E 7389

6. E-7389

7. Er 086526

8. Er-086526

9. Er-86526

10. Er086526

11. Eribulin

12. Eribulin (as Mesylate)

13. Eribulin Mesilate

14. Eribulin Monomethanesulfonate

15. Halaven

16. Nsc 707389

17. Nsc-707389

18. Nsc707389

2.3.2 Depositor-Supplied Synonyms

1. Halaven

2. Eribulin Mesilate

3. 441045-17-6

4. Eribulin (mesylate)

5. Eribulin Mesylate [usan]

6. Eribulin (as Mesylate)

7. E7389

8. Eribulin Monomethanesulfonate

9. Av9u0660cw

10. Chebi:70710

11. E 7389

12. E-7389

13. Eribulin Mesilate (jan)

14. Eribulin Mesylate (usan)

15. B-1939

16. (1s,3s,6s,9s,12s,14r,16r,18s,20r,21r,22s,26r,29s,31r,32s,33r,35r,36s)-20-[(2s)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one;methanesulfonic Acid

17. Eribulin Mesilate [jan]

18. Nsc-707389

19. Er-086526

20. Unii-av9u0660cw

21. Halaven (tn)

22. B1939 Mesylate

23. E7389 Mesylate

24. Er-086526 Mesylate

25. Chembl1683544

26. Eribulin Mesylate [vandf]

27. Eribulin Mesilate [mart.]

28. Eribulin Mesilate [who-dd]

29. Ex-a4873

30. Eribulin Mesylate [ema Epar]

31. Hy-13442a

32. Eribulin Mesylate [orange Book]

33. Eribulin Monomethanesulfonate [mi]

34. D08914

35. Q27882076

36. B1939 Mesylate; E7389 Mesylate; Er-086526 Mesylate

37. (2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)-2-((2s)-3-amino-2-hydroxypropyl)-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo(3,2-i)furo(2',3':5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5(4h)-one Methanesulfonate (salt)

38. 11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo(3,2-i)furo(2',3':5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5(4h)-one, 2-((2s)-3- Amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)-, 2r,3r,3as,7r,8as,9s,10ar,11s,12r,13ar,13bs,15s,18s,21s,24s,26r,28r,29as)-, Methanesulfonate (salt)

39. 2-(3-amino-2-hydroxypropyl)hexacosahydro-3-methoxy-26-methyl-20,27-bis(methylene)11,15-18,21-24,28-triepoxy-7,9-ethano-12,15-methano-9h,15h-furo(3,2-i)furo(2',3'-5,6)pyrano(4,3-b)(1,4)dioxacyclopentacosin-5-(4h)-one Methanesulfonate

2.4 Create Date
2007-11-26
3 Chemical and Physical Properties
Molecular Weight 826.0 g/mol
Molecular Formula C41H63NO14S
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count15
Rotatable Bond Count4
Exact Mass825.39692686 g/mol
Monoisotopic Mass825.39692686 g/mol
Topological Polar Surface Area209 Ų
Heavy Atom Count57
Formal Charge0
Complexity1470
Isotope Atom Count0
Defined Atom Stereocenter Count19
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameHalaven
PubMed HealthEribulin (Injection)
Drug ClassesAntineoplastic Agent
Drug LabelHALAVEN (eribulin mesylate) Injection is a non-taxane microtubule dynamics inhibitor. Eribulin mesylate is a synthetic analogue of halichondrin B, a product isolated from the marine sponge Halichondria okadai. The chemical name for eribulin mesyl...
Active IngredientEribulin mesylate
Dosage FormSolution
RouteIntravenous
Strength1mg/2ml (0.5mg/ml)
Market StatusPrescription
CompanyEisai

2 of 2  
Drug NameHalaven
PubMed HealthEribulin (Injection)
Drug ClassesAntineoplastic Agent
Drug LabelHALAVEN (eribulin mesylate) Injection is a non-taxane microtubule dynamics inhibitor. Eribulin mesylate is a synthetic analogue of halichondrin B, a product isolated from the marine sponge Halichondria okadai. The chemical name for eribulin mesyl...
Active IngredientEribulin mesylate
Dosage FormSolution
RouteIntravenous
Strength1mg/2ml (0.5mg/ml)
Market StatusPrescription
CompanyEisai

4.2 Drug Indication

Halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5. 1). Prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.

Halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5. 1).


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Microtubule Inhibitor [EPC]; Microtubule Inhibition [PE]
5.2 ATC Code

L01XX41


API SUPPLIERS

read-more
read-more

01

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Dr Reddy Company Banner

02

Transo-Pharm USA LLC

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF US arrow-down AUDIT
Transo Pharm USA Company Banner

03

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

04

Dr. Reddy's Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Dr Reddy Company Banner

05

Chongqing Sintaho Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Chongqing Sintaho Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Zhejiang Raybow Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Zhejiang Raybow Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Suzhou Tianma Pharma Group Co Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Suzhou Tianma Pharma Group Co Ltd

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Natco Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Natco Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Lianyungang Runzhong Pharmaceutica...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Lianyungang Runzhong Pharmaceutica...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

10

Wisdom Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

STLE Annual Meeting
Not Confirmed
arrow

Wisdom Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
STLE Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2022-02-03

Pay. Date : 2021-12-17

DMF Number : 36433

Submission : 2021-11-30

Status : Active

Type : II

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 35948

Submission : 2021-05-27

Status : Active

Type : II

Dr Reddy Company Banner

03

STLE Annual Meeting
Not Confirmed

03

STLE Annual Meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-05-14

Pay. Date : 2019-03-27

DMF Number : 33425

Submission : 2019-03-14

Status : Active

Type : II

blank

04

STLE Annual Meeting
Not Confirmed

04

STLE Annual Meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-02-08

Pay. Date : 2020-11-06

DMF Number : 35118

Submission : 2020-10-28

Status : Active

Type : II

blank

05

STLE Annual Meeting
Not Confirmed

06

STLE Annual Meeting
Not Confirmed

07

STLE Annual Meeting
Not Confirmed

07

STLE Annual Meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 36628

Submission : 2022-04-29

Status : Active

Type : II

blank

08

Natco Pharma Ltd

India

USDMF

arrow
STLE Annual Meeting
Not Confirmed

08

STLE Annual Meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-02-15

Pay. Date : 2022-01-11

DMF Number : 36605

Submission : 2022-01-06

Status : Active

Type : II

blank

09

STLE Annual Meeting
Not Confirmed

09

10

STLE Annual Meeting
Not Confirmed

10

STLE Annual Meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-09-29

Pay. Date : 2021-07-12

DMF Number : 35523

Submission : 2021-01-13

Status : Active

Type : II

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin mesylate

Registration Number : 304MF10030

Registrant's Address : Building C25-C28, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China...

Initial Date of Registration : 2022-02-10

Latest Date of Registration : 2022-02-10

blank

02

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin mesylate

Registration Number : 301MF10104

Registrant's Address : 4-6-10 Koishikawa, Bunkyo-ku, Tokyo

Initial Date of Registration : 2019-12-10

Latest Date of Registration : 2019-12-10

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Eisai

Japan
STLE Annual Meeting
Not Confirmed
arrow

Eisai

Japan
arrow
STLE Annual Meeting
Not Confirmed

Eribulin mesylate

Registrant Name : Korea Ezai Co., Ltd.

Registration Date : 2012-08-09

Registration Number : Su3834-1-ND

Manufacturer Name : Kashima Plant, Eisai Co., Lt...

Manufacturer Address : 22 Sunayama, Kamisu-shi, Ibaraki-ken 314-0255

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

ERIBULIN MESYLATE

NDC Package Code : 71796-044

Start Marketing Date : 2021-11-30

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Dr Reddy Company Banner

02

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 11071-892

Start Marketing Date : 2010-11-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

03

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 11071-891

Start Marketing Date : 2010-11-15

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

04

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN

NDC Package Code : 14593-949

Start Marketing Date : 2023-06-16

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (15kg/15kg)

Marketing Category : BULK INGREDIENT

blank

05

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 14593-945

Start Marketing Date : 2021-03-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10g/10g)

Marketing Category : BULK INGREDIENT

blank

06

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 66499-0074

Start Marketing Date : 2020-11-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

07

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 61662-0019

Start Marketing Date : 2023-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

08

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 58272-208

Start Marketing Date : 2012-06-08

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

09

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 13612-0022

Start Marketing Date : 2021-05-14

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (10g/10g)

Marketing Category : BULK INGREDIENT

blank

10

Chongqing Biocare Pharmaceutical Lt...

Country
STLE Annual Meeting
Not Confirmed
arrow

Chongqing Biocare Pharmaceutical Lt...

Country
arrow
STLE Annual Meeting
Not Confirmed

ERIBULIN MESYLATE

NDC Package Code : 33656-0018

Start Marketing Date : 2022-04-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Eribulin

About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...

Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfolio that provides high-quality, low-cost APIs to leading pharma companies in 80+ countries. It has 8 USFDA-inspected facilities – 6 in India & 1 each in Mexico & the UK & are inspected by international regulatory authorities on a regular basis. Its facilities are supplemented by formulation facilities that provide a wide range of dosage forms. Product(s) under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act and not for commercial sale
Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content

Eribulin Mesylate

About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...

Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout the entire API life cycle, from product development through sales. Transo-Pharm serves as a sourcing and regulatory marketing agent for API manufacturers. It aids clients in establishing DMFs and provides GMP consulting. With a dedicated regulatory department, a warehouse, proprietary IPs for API processes, and partnerships with laboratories, Transo-Pharm offers a wide range of services. It operates from its offices in Shanghai, Hong Kong, Singapore, and the US.
Transo Pharm USA Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Eribulin Mesylate

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

04

ALP Pharm

China
STLE Annual Meeting
Not Confirmed
arrow

ALP Pharm

China
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts...

ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts in the USA, United Kingdom, and India have more than 10 years of Western cGMP experience. Prior to working for ALP Pharm, they have helped more than 30 pharmaceutical companies achieve ANDAs and DMFs and also helped some branded companies to pass FDA inspections for the NDA and IND. Meanwhile, they helped some European pharmaceutical companies to get licenses for finished drugs including oral solid dosages and injections, as well as COSs and EDMFs.
blank

05

Apino Pharma

China
STLE Annual Meeting
Not Confirmed
arrow

Apino Pharma

China
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : Apino Pharma prides itself on being an innovation-driven company that strives to continuously improve its products and services. Our dedicated innovation team collaborates with the...

Apino Pharma prides itself on being an innovation-driven company that strives to continuously improve its products and services. Our dedicated innovation team collaborates with the world’s leading research institutes and universities to develop cutting-edge formulations and technologies that bring value to our customers. We are committed to exploring new opportunities presented by technology, science and global best practices to provide quality products and services that meet and exceed our customers’ needs.
blank

06

Aspen Bio

India
STLE Annual Meeting
Not Confirmed
arrow

Aspen Bio

India
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : Aspen Bio is a multifaceted company that was established in 2014. Aspen Bio defines development and novelty as a challenge for competitive markets to provide improved health servic...

Aspen Bio is a multifaceted company that was established in 2014. Aspen Bio defines development and novelty as a challenge for competitive markets to provide improved health services to people, through pioneering Research & Development in agreement with the latest principles to ensure safe and secured wellness. The Company is established in bringing the benefit of high quality APIs & Finished Formulations, yet reasonably priced, to patients in India and other emerging markets.
blank

07

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...

BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.
blank

08

STLE Annual Meeting
Not Confirmed
arrow
arrow
STLE Annual Meeting
Not Confirmed

Eribulin Mesylate

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

09

Hetero Drugs

India
STLE Annual Meeting
Not Confirmed
arrow

Hetero Drugs

India
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

10

Natco Pharma

India
STLE Annual Meeting
Not Confirmed
arrow

Natco Pharma

India
arrow
STLE Annual Meeting
Not Confirmed

Eribulin

About the Company : NATCO PHARMA LIMITED was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 e...

NATCO PHARMA LIMITED was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, NATCO today has five manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.NATCO family currently consists of more than 2500 employees, we are consistently ranked among fastest growing pharmaceutical companies in India. NATCO is well recognized for its innovation in Pharmaceutical R&D.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622399400,"product":"PHARMACEUTICAL RAW MATERIAL ERIBULIN MES YLATE BATCH NO. H20P0067 MFG DT 20.11.20 20 RETEST DT.21.11.2021","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"EMCURE PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"NEWARK NJ","customer":"PHARMACEUTICALS INTERNATIONAL INC.","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.585","unit":"GMS","unitRateFc":"150434.6","totalValueFC":"86563.3","currency":"USD","unitRateINR":10838811.606837608,"date":"31-May-2021","totalValueINR":"6340704.79","totalValueInUsd":"86563.3","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"2126632","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"T-184, MIDC, BHOSARI,PUNE, PUNE-MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"ERIBULIN MESYLATE","year":"2021","qtr":"Q2","strtotime":1622399400,"product":"PHARMACEUTICAL RAW MATERIAL WORKING STAN DARD ERIBULIN MESYLATE REFRANCE STANDARD BATCH NO.EBM\/R-376\/2526\/102 VALID FROM","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"EMCURE PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"NEWARK NJ","customer":"PHARMACEUTICALS INTERNATIONAL INC.","customerCountry":"UNITED STATES","quantity":"0.00","actualQuantity":"0.45","unit":"GMS","unitRateFc":"150434.6","totalValueFC":"66587.2","currency":"USD","unitRateINR":10838812.022222223,"date":"31-May-2021","totalValueINR":"4877465.41","totalValueInUsd":"66587.2","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"2126632","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"T-184, MIDC, BHOSARI,PUNE, PUNE-MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680114600,"product":"ERIBULIN MESYLATE","address":"A-2,419, CELEBRATION CITY CENTER,, GALA GYM ROAD,SOUTH BOPAL,BOPAL","city":"AHMEDABAD,GUJARAT","supplier":"APRAMEYA PHARMACHEM PVT LTD","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"WARM ISTANBUL WARD NAKLIYE,","customerCountry":"TURKEY","quantity":"0.00","actualQuantity":"0.1","unit":"GMS","unitRateFc":"56999.5","totalValueFC":"5969.6","currency":"EUR","unitRateINR":4910000,"date":"30-Mar-2023","totalValueINR":"491000","totalValueInUsd":"5969.6","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"8943435","productDescription":"API","marketType":"","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"A-2,419, CELEBRATION CITY CENTER,, GALA GYM ROAD,SOUTH BOPAL,BOPAL, AHMEDABAD,GUJARAT","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1612722600,"product":"ERIBULIN N-6 [20 GMS]","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"NINGBO LOTUS IMPORT ","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"3500000","totalValueFC":"70955","currency":"USD","unitRateINR":"258300000","date":"08-Feb-2021","totalValueINR":"5166000","totalValueInUsd":"70955","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"2671684","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q1","strtotime":1616610600,"product":"ERIBULIN FRAGMENT-B+C(QTY: 250MG, VALUE: USD 300.1)","address":"7-1-27, AMEERPET","city":"HYDERABAD, ANDHRA PRADESH","supplier":"ABYDOS SCIENTIFIC","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00025","unit":"KGS","unitRateFc":"1200400","totalValueFC":"449.7","currency":"USD","unitRateINR":"130958360","date":"25-Mar-2021","totalValueINR":"32739.59","totalValueInUsd":"449.7","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"3290013","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"","customerAddress":"7-1-27, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623263400,"product":"ERIBULIN N-6 ERIBULINLNTERMEDIATE [40 GMS] (R);7,11:10, 14:21,24:27,31-TERAEPOXY-5H-CYCLOHENTRIACONTA(B)FURAN-5-ONE,2-[","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"PHARMACEUTICAL TECHNOLOGY","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.04","actualQuantity":"0.04","unit":"KGS","unitRateFc":"3250000","totalValueFC":"130714.8","currency":"USD","unitRateINR":"240337500","date":"10-Jun-2021","totalValueINR":"9613500","totalValueInUsd":"130714.8","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"4269499","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626114600,"product":"ERIBULIN INTERMEDIATE N-5","address":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD","supplier":"HANGZHOU LONGSHINE BIO-TECH","supplierCountry":"CHILE","foreign_port":"BEIJING","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"5525000","totalValueFC":"139558.1","currency":"USD","unitRateINR":"416032500","date":"13-Jul-2021","totalValueINR":"10400812.5","totalValueInUsd":"139558.1","indian_port":"MADRAS AIR","hs_no":"29339990","bill_no":"4658632","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHILE","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"","customerAddress":"HETERO HOUSE,H.NO.8-3-166\/7\/1ERRAGADDA"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626805800,"product":"ERIBULIN N-6 ERIBULINLNTERMEDIATE [5 GMS] (R);7,11:10, 14:21,24:27,31-TERAEPOXY-5H-CYCLOHENTRIACONTA(B)FURAN-5-ONE,2-[(","address":"T-184, MIDC, BHOSARI,PUNE","city":"PUNE-MAHARASHTRA","supplier":"PHARMACEUTICAL TECHNOLOGY","supplierCountry":"CHINA","foreign_port":"","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"3250000","totalValueFC":"16440.4","currency":"USD","unitRateINR":"245050000","date":"21-Jul-2021","totalValueINR":"1225250","totalValueInUsd":"16440.4","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"4762397","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638469800,"product":"ERIBULIN N -6 (45 GMS) ERIBULINNTERMEDIATE(R) 7,11;10, 14;21, 24;27,31-TETRAEPOXY-5H-CYCLOHENTRIACONTA(B)FURAN-5-ONE,2-[","address":"T-184, MIDC, BHOSARI,,PUNE","city":"PUNE,MAHARASHTRA","supplier":"PHARMACEUTICAL TECHNOLOGY","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"0.045","unit":"KGS","unitRateFc":"3200000","totalValueFC":"144904.6","currency":"USD","unitRateINR":"242880000","date":"03-Dec-2021","totalValueINR":"10929600","totalValueInUsd":"144904.6","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"6517212","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640197800,"product":"ERIBULIN INTERMEDIATE N-5","address":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta","city":"HYDERABAD","supplier":"HANGZHOU LONGSHINE BIO-TECH","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"5000000","totalValueFC":"127856.8","currency":"USD","unitRateINR":"385750000","date":"23-Dec-2021","totalValueINR":"9643750","totalValueInUsd":"127856.8","indian_port":"MADRAS AIR","hs_no":"29339990","bill_no":"6802375","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"","customerAddress":"HETERO CORPORATE, NO. 7-2-A2, INDUSTRIAL ESTATE,SANATHNAGAR Conta"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1640975400,"product":"ERIBULIN INTERMEDIATE (S-4) (CAS NO.253128-10-8) (QTY - 10 GRAM )","address":"T-184, MIDC, BHOSARI,,PUNE","city":"PUNE,MAHARASHTRA","supplier":"ABYDOS SCIENTIFIC","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"1000000","totalValueFC":"10356.6","currency":"USD","unitRateINR":"77150000","date":"01-Jan-2022","totalValueINR":"771500","totalValueInUsd":"10356.6","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"6917291","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"ERIBULIN MESYLATE","address":"Plot No 55 and 45 TSIIC BIOTECH Phase-III Karakapatla Conta","city":"MEDAK","supplier":"HANGZHOU QICHUANG","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0015","unit":"KGS","unitRateFc":"30000000","totalValueFC":"45487.2","currency":"USD","unitRateINR":"2259000000","date":"27-Jan-2022","totalValueINR":"3388500","totalValueInUsd":"45487.2","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"7242049","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"Plot No 55 and 45 TSIIC BIOTECH Phase-III Karakapatla Conta"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1648751400,"product":"ERIBULIN INTERMEDIATE N-5","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HANGZHOU LONGSHINE BIO-TECH","supplierCountry":"CHINA","foreign_port":"NA","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"4980000","totalValueFC":"253788.9","currency":"USD","unitRateINR":"382962000","date":"01-Apr-2022","totalValueINR":"19148100","totalValueInUsd":"253788.9","indian_port":"MADRAS AIR","hs_no":"29349990","bill_no":"8106983","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657650600,"product":"ERIBULIN INTERMEDIATE","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"HANGZHOU PROSERRE CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"MSN LABORATORIES","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"2700000","totalValueFC":"135651","currency":"USD","unitRateINR":"215730000","date":"13-Jul-2022","totalValueINR":"10786500","totalValueInUsd":"135651","indian_port":"MADRAS AIR","hs_no":"29349990","bill_no":"9525926","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659897000,"product":"ERIBULIN INTERMEDIATE N-6 ( 10 GRAM )","address":"T-184, MIDC, BHOSARI,,PUNE","city":"PUNE,MAHARASHTRA","supplier":"ZENJI RESEARCH LABORATORIES","supplierCountry":"CHINA","foreign_port":"NA","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"3200000","totalValueFC":"32274.6","currency":"USD","unitRateINR":"256800000","date":"08-Aug-2022","totalValueINR":"2568000","totalValueInUsd":"32274.6","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"9920314","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668796200,"product":"ERIBULIN INTERMEDIATE N-6 [121 GMS]","address":"T-184, MIDC, BHOSARI,,PUNE","city":"PUNE,MAHARASHTRA","supplier":"ZENJI RESEARCH LABORATORIES","supplierCountry":"CHINA","foreign_port":"NA","customer":"EMCURE PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.12","actualQuantity":"0.121","unit":"KGS","unitRateFc":"3500000","totalValueFC":"428623.4","currency":"USD","unitRateINR":"289100000","date":"19-Nov-2022","totalValueINR":"34981100","totalValueInUsd":"428623.4","indian_port":"BOMBAY AIR","hs_no":"29321990","bill_no":"3377288","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"T-184, MIDC, BHOSARI,,PUNE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713119400,"product":"ERIBULIN INTERMEDIATE;ERIBULIN N-6","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MILVERPHARMA PVT LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MSN LABORATORIES","customerCountry":"INDIA","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"1650000","totalValueFC":"83332.5","currency":"USD","unitRateINR":"139177500","date":"15-Apr-2024","totalValueINR":"6958875","totalValueInUsd":"83332.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3030786","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"9TH FLOOR,1#,NO.98 CHUANGYUAN RD,HI-TECH ZONE NINGBO CHINA 315040SDNF CN","customerAddress":"MSN HOUSE, PLOT NO. C-24,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731004200,"product":"ERIBULIN MESYLATE ( 5 G )","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"0.01","actualQuantity":"0.005","unit":"KGS","unitRateFc":"12500000","totalValueFC":"63101.3","currency":"USD","unitRateINR":"1065000000","date":"08-Nov-2024","totalValueINR":"5325000","totalValueInUsd":"63101.3","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"6569533","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"BUILDING C25-C28,NO.218 XINGHU ROAD ,SUZHOU IND PARK SDNF China","customerAddress":"101, SITARAM MANSION,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1742927400,"product":"ERIBULIN MESYLATE ( 15 G) ERIBULIN MESYLATE ( 15 G)","address":"101, SITARAM MANSION,","city":"KAROL BAGH, NEW DELHI","supplier":"BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO.,LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"JODAS EXPOIM PVT. LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.015","unit":"KGS","unitRateFc":"12000000","totalValueFC":"181418.1","currency":"USD","unitRateINR":"1047600000","date":"26-Mar-2025","totalValueINR":"15714000","totalValueInUsd":"181418.1","indian_port":"Hyderabad Air","hs_no":"29419090","bill_no":"9115197","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"BUILDING C25-C28 NO.218 XINGHU ROAD ,SUZHOU INDUSTRIAL PARK SDNF China","customerAddress":"101, SITARAM MANSION,"}]
08-Feb-2021
26-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 441045-17-6 / Eribulin API manufacturers, exporters & distributors?

Eribulin manufacturers, exporters & distributors 1

74

PharmaCompass offers a list of Eribulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eribulin manufacturer or Eribulin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eribulin manufacturer or Eribulin supplier.

PharmaCompass also assists you with knowing the Eribulin API Price utilized in the formulation of products. Eribulin API Price is not always fixed or binding as the Eribulin Price is obtained through a variety of data sources. The Eribulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Eribulin

Synonyms

Halaven, Eribulin mesilate, 441045-17-6, Eribulin (mesylate), Eribulin mesylate [usan], Eribulin (as mesylate)

Cas Number

441045-17-6

Unique Ingredient Identifier (UNII)

AV9U0660CW

About Eribulin

Eribulin Mesylate is the mesylate salt of a synthetic analogue of halichondrin B, a substance derived from a marine sponge (Lissodendoryx sp.) with antineoplastic activity. Eribulin binds to the vinca domain of tubulin and inhibits the polymerization of tubulin and the assembly of microtubules, resulting in inhibition of mitotic spindle assembly, induction of cell cycle arrest at G2/M phase, and, potentially, tumor regression.

Eribulin Manufacturers

A Eribulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eribulin, including repackagers and relabelers. The FDA regulates Eribulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eribulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Eribulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Eribulin Suppliers

A Eribulin supplier is an individual or a company that provides Eribulin active pharmaceutical ingredient (API) or Eribulin finished formulations upon request. The Eribulin suppliers may include Eribulin API manufacturers, exporters, distributors and traders.

click here to find a list of Eribulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Eribulin USDMF

A Eribulin DMF (Drug Master File) is a document detailing the whole manufacturing process of Eribulin active pharmaceutical ingredient (API) in detail. Different forms of Eribulin DMFs exist exist since differing nations have different regulations, such as Eribulin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Eribulin DMF submitted to regulatory agencies in the US is known as a USDMF. Eribulin USDMF includes data on Eribulin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eribulin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Eribulin suppliers with USDMF on PharmaCompass.

Eribulin JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Eribulin Drug Master File in Japan (Eribulin JDMF) empowers Eribulin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Eribulin JDMF during the approval evaluation for pharmaceutical products. At the time of Eribulin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Eribulin suppliers with JDMF on PharmaCompass.

Eribulin KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Eribulin Drug Master File in Korea (Eribulin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eribulin. The MFDS reviews the Eribulin KDMF as part of the drug registration process and uses the information provided in the Eribulin KDMF to evaluate the safety and efficacy of the drug.

After submitting a Eribulin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eribulin API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Eribulin suppliers with KDMF on PharmaCompass.

Eribulin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eribulin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Eribulin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Eribulin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Eribulin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eribulin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Eribulin suppliers with NDC on PharmaCompass.

Eribulin GMP

Eribulin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Eribulin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eribulin GMP manufacturer or Eribulin GMP API supplier for your needs.

Eribulin CoA

A Eribulin CoA (Certificate of Analysis) is a formal document that attests to Eribulin's compliance with Eribulin specifications and serves as a tool for batch-level quality control.

Eribulin CoA mostly includes findings from lab analyses of a specific batch. For each Eribulin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Eribulin may be tested according to a variety of international standards, such as European Pharmacopoeia (Eribulin EP), Eribulin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eribulin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty